Detection of Clopidogrel Hyporesponsiveness Using a Point-of-Care Assay and the Impact of Additional Cilostazol Administration after Coronary Stent Implantation in Diabetic Patients
Tae-Hyun Yang, Doo-Il Kim, Dong-Kie Kim, Jae-Sik Jang, Ung Kim, Sang-Hoon Seol, Dae-Kyeong Kim, Geu-Ru Hong, Jong-Seon Park, Dong-Gu Shin, Young-Jo Kim, Yun-Kyeong Cho, Chang-Wook Nam, Seung-Ho Hur, Kwon-Bae Kim, Dong-Soo Kim
Korean J Intern Med. 2011;26(2):145-152.   Published online 2011 Jun 1     DOI: https://doi.org/10.3904/kjim.2011.26.2.145
Citations to this article as recorded by Crossref logo
Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
Hongtao Lu, Wenjun Guan, Yanhua Zhou, Zhangui Tang, Hong Bao
Diabetes Therapy.2019; 10(3): 937.     CrossRef
A pharmacodynamic study of the optimal P2Y12inhibitor regimen for East Asian patients with acute coronary syndrome
Ji Hyun Lee, Sung Gyun Ahn, Bonil Park, Sang Wook Park, Yong Seok Kang, Jun-Won Lee, Young Jin Youn, Min-Soo Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon
The Korean Journal of Internal Medicine.2015; 30(5): 620.     CrossRef
Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials
Pravesh Kumar Bundhun, Tao Qin, Meng-Hua Chen
BMC Cardiovascular Disorders.2015;[Epub]     CrossRef
Comparison of Antiplatelet Effect and Safety of Clopidogrel Napadisilate with Clopidogrel Bisulfate in Coronary Artery Disease Patients: Multi-center, Randomized, Double-blind, Phase IV, Non-inferiority Clinical Trial
Sahmin Lee, Hae-Young Lee, Kyung-Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Hyo-Soo Kim, Dong-Ju Choi, Myung-A Kim, Byung-Hee Oh
American Journal of Cardiovascular Drugs.2013; 13(6): 413.     CrossRef
Comparison of On-Treatment Platelet Reactivity Between Triple Antiplatelet Therapy With Cilostazol and Standard Dual Antiplatelet Therapy in Patients Undergoing Coronary Interventions
Hemang B. Panchal, Tejaskumar Shah, Parthavkumar Patel, Kais Albalbissi, Janos Molnar, Brandon Coffey, Sandeep Khosla, Vijay Ramu
Journal of Cardiovascular Pharmacology and Therapeutics.2013; 18(6): 533.     CrossRef
Dual Antiplatelet Therapy Clopidogrel with Low-dose Cilostazol Intensifies Platelet Inhibition in Patients with Ischemic Stroke
Hajime Maruyama, Takuya Fukuoka, Ichiro Deguchi, Yasuko Ohe, Harumitsu Nagoya, Yuji Kato, Yohsuke Horiuchi, Takeshi Hayashi, Norio Tanahashi
Internal Medicine.2013; 52(10): 1043.     CrossRef